(Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that Laura Niklason, M.D., Ph.D., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback